Structural Basis for the Proinflammatory Cytokine Activity of High Mobility Group Box 1

Bustin M. (2001) Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem. Sci. 26:152–4.

Goodwin GH, Sanders C, Johns EW. (1973) A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem. 38:14–9.

Bianchi ME, Beltrame M, Paonessa G. (1989) Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243:1056–9.

Maher JF, Nathans D. (1996) Multivalent DNA-binding properties of the HMG-1 proteins. Proc. Natl. Acad. Sci. U.S.A. 93:6717–20.

Hughes EN, Engelsberg BN, Billings PC. (1992) Purification of nuclear proteins that bind to cisplatin-damaged DNA. J. Biol. Chem. 267:13520–7.

Melvin VS, Edwards DP. (1999) Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids 64:576–86.

Bustin M, Lehn DA, Landsman D. (1990) Structural features of the HMG chromosomal proteins and their gene. Biochim Biophys Acta. 1049:231–43.

Weir HM et al. (1993) Structure of the HMG box motif in the B-domain of HMG1. EMBO J. 12:1311–9.

Hardman CH et al. (1995) Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear 3- and 4-dimensional NMR spectroscopy. Biochemistry 34:16596–607.

Baxevanis AD, Landsman D. (1995) The HMG-1 box protein family: classification and functional relationship. Nucleic Acids Res. 23:1604–13.

Calogero S et al. (1999) The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycemia in newborn mice. Nature Genet. 22:276–80.

Wang H et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–51.

Andersson U et al. (2000) HMG-1 stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565–70.

Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. (2000) HMG-1 as a mediator of acute lung injury. J. Immunol. 165:2950–4.

Wang H et al. (1999) Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126:389–92.

Ombrellino M et al. (2000) Increased serum concentrations of high-mobility-group protein 1 in hemorrhagic shock. Lancet 354:1446–7.

Agnello D, Wang H, Tracey KJ, Ghezzi P. (2002) HMGB1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 18:231–6.

Parkkinen J, Rauvala H. (1991) Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J. Biol. Chem. 266:16730–5.

Rauvala H, Pihlaakari R. (1987) Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J. Biol. Chem. 262:16625–5.

Degryse B et al. (2001) The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152:1192–206.

Gardella S et al. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3:995–1001.

Scaffidi P, Misteli T, Bianchi ME. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191–5.

Yang H et al (2001) The HMG B box confers cytokine activity and signals via RAGE. Shock 15(suppl):27.

Sappington PL et al. (2002) HMGB1 B Box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123:790–802.

Wichmann MW, Haisken JM, Ayala A, Chaudry IH. (1996) Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge. J. Surgery Res. 65:109–14.

Galanos C, Freudenberg MA, Reutter W. (1979) Galactosamine-induced sensitation of the lethal effects of endotoxin. Proc. Natl. Acad. Sci. U.S.A. 76:5939–43.

Lehmann V, Freudenberg MA, Galanos C. (1987) Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and d-galactosamine-treated mice. J. Exp. Med. 165:657–63.

Bianchi M et al. (1996) Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone J. Exp. Med. 183:927–36.

Poltorak A et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–8.

Hsu H, Xiong J, Goeddel DV. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:495–504.

Barnes PJ, Karin M. (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066–71.

Hellerbrand C, Jobin C, Licato LL, Sartor RB, Brenner DA. (1998) Cytokines induce NF-κB in activated but not in quiescent rat hepatic stellate cells. Am. J. Physiol. 275:G269–78.

Fiuza C et al. (2002) Inflammatory promoting activity of HMGB1 on human microvascular endothelial cells. Blood. Forthcoming.

Ulloa L et al. (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. U.S.A. 99:12351–6.

Landsman D, Bustin M. (1993) A signature for the HMG-1 box DNA-binding proteins. Bioessays 15:539–46.

Bachvarov D, Moss T. (1991) The RNA polymerase I transcription factor xUBF contains 5 tandemly repeated HMG homology boxes. Nucleic Acids Res. 19:2331–5.

Van de Wetering M, Oosterwegel M, Dooijes D, Clevers H. (1991) Identification and cloning of TCF-1, a T-lymphocyte-specific transcription factor containing a sequence specific HMG box. EMBO J. 10:123–32.

Sinclair AH et al. (1990) A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240–4.

Tracey KJ et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470–4.

Yang H, Wang H, Tracey KJ. 2001. HMG-1 rediscovered as a cytokine. Shock 15:247–53.